Vazquez Chris 4
4 · BIODESIX INC · Filed Nov 13, 2025
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Vazquez Chris
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-11-10$7.62/sh−13$99→ 936 total - Exercise/Conversion
Common Stock
2025-11-10+31→ 949 total - Exercise/Conversion
Restricted Stock Units
2025-11-10−31→ 29 total→ Common Stock (31 underlying)
Footnotes (4)
- [F1]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
- [F2]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F4]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.